PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Puerarin has shown promising cardioprotective potential in preclinical studies [PMID:41924138]
Kudzu root-derived carbon dots (KRCDs) significantly lowered fasting glucose, improved glucose tolerance and insulin sensitivity, and reduced hepatic steatosis in diabetic mice [PMID:41494302]
Pueraria montana was found to protect rats from developing kidney tumors induced by DEN and Fe-NTA by ameliorating inflammation and oxidative stress [PMID:36089399]
Kudzu root has been proven effective for treating osteoporosis, with biological validation in a zebrafish model [PMID:39940967]
Ge-Gen decoction (GGD) alleviated symptoms in a rat model [PMID:38594870]
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 40714420 (2025) — Plant-derived exosomes: Unveiling the similarities and disparities between conventional extract and innovative form. · Phytomedicine : international journal of phytotherapy and phytopharmacology
- 2.PMID: 17980785 (2007) — Pueraria lobata (Kudzu root) hangover remedies and acetaldehyde-associated neoplasm risk. · Alcohol (Fayetteville, N.Y.)
- 3.PMID: 39940967 (2025) — Network Pharmacology Analysis and Biological Validation Systemically Identified the Active Ingredients and Molecular Targets of Kudzu Root on Osteoporosis. · International journal of molecular sciences
- 4.PMID: 40091443 (2025) — Advancing the Identification of Bioactive Molecules and the Construction of a Synergistic Drug Delivery System in Combating Lung Injury. · Advanced science (Weinheim, Baden-Wurttemberg, Germany)
- 5.PMID: 36089399